Clinical Trial

The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron

Completed Phase 4
View on ClinicalTrials.gov →
Summary
Perioperative anaphylaxis is a potentially life-threatening drug allergic reaction that can occur during anesthetic procedures. The purpose of this research is to determine the maximal nonirritating skin testing concentrations of midazolam, ketamine and ondansetron. These drugs are FDA approved and commonly used before, during and after surgical procedures.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-08-01; most recent amendment 2026-03-27.
Status change: Recruiting → Completed 2026-03-27
Status change: Not Yet Recruiting → Recruiting 2025-11-17
Trial Details
NCT Number NCT07103720
Lead Sponsor Mayo Clinic
Collaborators: Arizona Biomedical Research Commission (ABRC)
Conditions Allergy
Enrollment 21 participants
Start Date 2025-11-05
Primary Completion 2026-03-10 (estimated)
Study Completion 2026-03-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-01